Omni Partners US’s PRA Health Sciences, Inc. PRAH Stock Holding History

Omni Partners US’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-544,675	Closed	-$90M	–	297
2021 Q2	$90M	Buy	+544,675	New	+$90.9M	3.97%	7

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Omni Partners US's PRAH Position: Q3 2021 in Review

Omni Partners US sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 544,675 shares — an estimated $90M sold.

Omni Partners US first reported a position in PRAH in Q2 2021 and held it in 1 quarter. The position peaked at $90M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Omni Partners US reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Omni Partners US sold 544,675 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $90M.
Omni Partners US first reported a position in PRA Health Sciences, Inc. in Q2 2021 and held it in 1 quarter.
Omni Partners US's PRA Health Sciences, Inc. position peaked at $90M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.